Export Snapshot

Minimum order

1 Piece

HSN Code

30049095

Origin

India

Lead time

On request

Port of dispatch

On request

Packaging

Standard export packaging

Shelf life / storage

As per product specification

Export markets served

US PH XG GB BD +46 others

Ability to customise

As per OEM brief

Values shown are for Radhakrushna Medicals.

Company Radhakrushna Medicals

Radhakrushna Medicals

"Radhakrushna Medicals: Your Destination for Critical Care & Speciality Medicines. Surgical Suture Vaccines  "

Registered address: Yavatmal, India. Industry: Healthcare, Medical Supplies & Pharmaceuticals › Drugs & Pharmaceuticals.

View profile →

Established

2022

Employees

1–10

GST

27AEMPT2491Q2ZF

IEC code

AEMPT2491Q

Export markets

US PH XG GB BD +46 others

Member since

Feb 2026

Turnover

$50,000 - $250,000

Incorporation type

On request

DRUG LICENCE 20B DRUG LICENCE 21B RCMC-PHARMAXCIL

Product details

Description

BORTLIEVA contains Bortezomib, a proteasome inhibitor used in cancer treatment. It works by blocking proteasomes in cells, leading to accumulation of proteins and apoptosis (cell death) of cancer cells.

Uses

Bortezomib is used in adults for:

1. Multiple myeloma

     – Newly diagnosed or relapsed/refractory

2. Mantle cell lymphoma

     – Previously treated patients

3. Sometimes in combination with other chemotherapies for certain hematologic cancers.

Side Effects

Common side effects:

•  Fatigue, weakness

•  Peripheral neuropathy (tingling/numbness)

•  Nausea, vomiting

•  Diarrhea or constipation

•  Low blood counts (thrombocytopenia, neutropenia)

Serious side effects:

•  Severe infections

•  Severe neuropathy

•  Heart problems (rare)

•  Liver function abnormalities

Monitor blood counts and liver function regularly.

Dosage

•  1.3 mg/m² IV or SC on Days 1, 4, 8, 11 of a 21-day cycle (common regimen)

•  Dose may be adjusted based on side effects or prior therapies

•  Can be given intravenously (IV) or subcutaneously (SC)

NOTE: This medicine should be taken only under a doctor’s supervision.

Description provided by Radhakrushna Medicals.

Bortezomib Injection IP 3.5mg

Treatment of Multiple Myeloma and Mantle Cell Lymphoma

Intravenous (IV) or Subcutaneous (SC) injection

Injection in 3.5 mg vial

Allieva Pharma Private Limited

India

Prescription required; Scheduled drug

Single Vial per Piece

Proteasome inhibitor causing cancer cell apoptosis

1.3 mg/m² on Days 1, 4, 8, 11 in a 21-day cycle

Specifications

Product Name

BORTLIEVA (Bortezomib Injection IP 3.5mg)

Dosage Strength

3.5 mg per vial

Active Pharmaceutical Ingredient (API)

Bortezomib

Formulation

Injection

Route of Administration

IV / SC

Therapeutic Category

Anti-Cancer, Oncology

Indications

Multiple Myeloma, Mantle Cell Lymphoma

Manufacturer

Allieva Pharma Private Limited

Country of Origin

India

Prescription Requirement

Yes

Packaging Type

Vial

MOQ

1 Piece

Storage Conditions

Store as per physician's instructions

Use cases

Category

Pharmaceuticals > Oncology Medicines > Anti-Cancer Injections

Primary application

Brand

Not specified

Product type

Product

Logistics & handling

Lead time

On request

Packaging

As per buyer requirement

Storage condition

As recommended by supplier

Origin

India

Form

As listed by supplier

Commercials Radhakrushna Medicals

Minimum order

1 Piece

Lead time

On request

Payment terms

As per negotiated commercial agreement

Frequently asked by buyers

What cancers is BORTLIEVA Injection indicated for?

BORTLIEVA is indicated for treating multiple myeloma—both newly diagnosed and relapsed/refractory—and mantle cell lymphoma in previously treated patients.

How is BORTLIEVA administered?

It can be administered either intravenously (IV) or subcutaneously (SC) in cycles, typically 1.3 mg/m² on Days 1, 4, 8, and 11 of a 21-day treatment cycle.

Are there any special storage instructions for BORTLIEVA Injection?

BORTLIEVA must be stored as per the manufacturer’s and physician’s recommendations to maintain stability, typically in a controlled temperature environment.

What are the common side effects of BORTLIEVA Injection?

Common side effects include fatigue, peripheral neuropathy, nausea, vomiting, diarrhea or constipation, and blood count abnormalities such as thrombocytopenia and neutropenia.

Is a prescription required to purchase BORTLIEVA?

Yes, BORTLIEVA is a prescription-only and scheduled anti-cancer drug, requiring authorization from a licensed healthcare professional.

Question not answered? Sellers typically reply within 24–48 hours. Ask a question

What similar products are available in this category?

Browse all →

surbhi herbal tea - an ayurvedic formulation

Hetha

From $ 5.44

MOQ 1 Piece

brahmi ghrita nasal drop

Hetha

From $ 5.10

MOQ 1 Piece

himalayan badri gaumutra (gomutra) ark

Hetha

From $ 3.97

MOQ 1 Piece

triphala gaumutra ark

Hetha

From $ 3.97

MOQ 1 Piece

desi cow gaumutra ark / gomutra ark

Hetha

From $ 3.40

MOQ 1 Piece

parijat aloevera gaumutra ark

Hetha

From $ 3.97

MOQ 1 Piece

kachnar gaumutra ark

Hetha

From $ 3.97

MOQ 1 Piece

tulsi giloy gaumutra ark

Hetha

From $ 3.97

MOQ 1 Piece

More from Radhakrushna Medicals